Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-19 · accession 0001883850-21-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-23 | 2021-11-19+ | REGN | SING GEORGE L | Dir | S - Sale | $656.67 | -3,000 | 31.9K | -9% | -$1.97M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-22 | S | D | 1,000 | $660.00 | 29,858 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-22 | S | D | 1,000 | $655.00 | 30,858 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-19 | S | D | 1,000 | $655.00 | 31,858 | D | — | — |